Vern de Biasi - Concepedia

Author

Vern de Biasi

GlaxoSmithKline (United Kingdom)

Also Known As

V De Biasi, Vern De Biasi, Vern de Biasi

Publications

575

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)GlaxoSmithKline (Italy)

About

Vern de Biasi is an author at GlaxoSmithKline (United Kingdom) specializing in engineering, medicine, and biomolecular engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	209
2	Medicine	4	4	126
3	Biomolecular Engineering	3	3	177
4	Natural Sciences	1	1	22
5	Biochemistry	1	1	22

Vern de Biasi

Publications

317

Citations

H-Index

Page 1

	Year	Citations
Approaches to the rational design of molecularly imprinted polymers Matthew Davies, Vern de Biasi, David I. Perrett Analytica Chimica Acta EngineeringRational DesignPolymer ScienceMolecular ImprintingMolecular Engineering	2003	105
Estimation of the Partitioning Characteristics of Drugs: A Comparison of a Large and Diverse Drug Series Utilizing Chromatographic and Electrophoretic Methodology M. M. Hanna, Vern de Biasi, Brian Bond, Analytical Chemistry	1998	64
Chiral separation of basic drugs by capillary electrophoresis with carboxymethylcyclodextrins Janusz Żukowski, Vern de Biasi, Alain Berthod Journal of Chromatography A EngineeringCapillary ElectrophoresisSeparation ScienceMedicineAnalytical Chemistry	2002	53
The analysis of basic and acidic compounds using non-aqueous CE and non-aqueous CE-MS John Senior, Delphine Rolland, David Tolson, Journal of Pharmaceutical and Biomedical Analysis Environmental ChemistryChemical EngineeringNon-aqueous Ce-msEngineeringChemical Composition	2000	32
Synthesis, chromatographic resolution and chiroptical properties of carboxyibuprofen stereoisomers: Major metabolites of ibuprofen in man Soo Choon Tan, James Α. Baker, Nichola Stevens, Chirality Human UrineCarboxyibuprofen StereoisomersMedicinal ChemistryChiroptical PropertiesPharmaceutical Science	1997	22
Chiral HPLC method for chiral purity determination of paroxetine drug substance Janusz Żukowski, Malcolm D. Brightwell, Vern de Biasi Chirality	2003	22
Removal of the fermentation by‐product succinyl <scp>L</scp>‐tyrosine from the β‐lactamase inhibitor clavulanic acid using a molecularly imprinted polymer Y. Bruce Yu, Lei Ye, Vern de Biasi, Biotechnology and Bioengineering Pharmaceutical ScienceEngineeringPharmaceutical ChemistryMedicinal ChemistryPenicillin-type Antibiotics	2002	19

Page 1